Upgrade to SI Premium - Free Trial

Aurora Cannabis (ACB) Acquiring Reliva is a Positive Step, Stifel Reiterates Sell

May 21, 2020 7:44 AM
Stifel analyst Andrew Carter reiterated a Sell rating and 6.20CAD price target on Aurora Cannabis (NYSE: ACB) but noted that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles